DCN and colorectal carcinoma: Our results were in accordance with previous studies: decorin was found to decrease in the ECM of primary CRC [75], as was osteoglycin, which can inhibit the transcription of hypoxia inducible factor-1α (HIF-1α) and vascular endothelial growth factor (VEGF) in CRC cells [33].